Industry · Early Pilots
Quantum Computing for Healthcare
Quantum computing's most scientifically grounded near-term application: simulating molecules for drug discovery and understanding biological systems at the quantum level.
Maturity
Early pilots; quantum sensing is further ahead than quantum computing
Strongest scientific case
Simulating molecules and reaction mechanisms
Hardware needed
Fault-tolerant machines with thousands of logical qubits for chemistry beyond classical reach
Strongest classical competition
Density functional theory, coupled cluster, AI structure prediction, and GPU molecular dynamics
Nearest-term quantum contribution
Sensing, such as optically pumped magnetometers for brain imaging
Realistic horizon
Early 2030s for first chemistry results; longer for clinical impact
Overview
Healthcare touches quantum technology in two quite different ways. The first is quantum computing in the strict sense: using quantum processors to simulate molecules, search large combinatorial spaces, and learn from data. The second is quantum sensing, where the quantum properties of atoms and spins are used to build extremely sensitive detectors, some of which already appear in medical research and are further along than computing.
On the computing side, the most scientifically solid prospect is simulating molecular and biochemical systems, which underpins drug discovery and is covered here from the clinical perspective. Other proposed uses, such as genomics, medical imaging, and treatment planning, are earlier-stage and often rely on hybrid methods that have not yet shown a measurable advantage over classical tools.
Why this industry is a candidate for quantum computing
Biology is chemistry, and chemistry is quantum mechanics. The interactions that decide how a drug binds to a protein, how an enzyme works, or how a molecule absorbs light depend on electron correlations that are exponentially expensive to describe on classical computers. Approximate classical methods work well for many cases, and a failure to capture strong correlations is a persistent limit for some important targets.
Healthcare also generates optimization problems, in scheduling, radiation therapy planning, and logistics, and a large volume of data for machine learning. These are areas where quantum algorithms are being explored, but where the honest summary is that advantage has not been shown and strong classical methods set a high bar.
Key facts and numbers
| Item | Detail |
|---|---|
| Drug development time | Commonly cited as 10 to 15 years from target to approval, at a cost of over a billion dollars per approved drug |
| Chemical accuracy target | About 1.6 millihartree, roughly 1 kcal per mole, needed to predict binding and reactivity |
| Metalloenzyme simulation | Resource estimates for cytochrome P450 and FeMoco point to millions of physical qubits and days of runtime |
| Cleveland Clinic and IBM | First IBM Quantum System One installed on a hospital campus in 2023 |
| Typical near-term demos | Small molecules and short sequences on roughly 2 to 100 qubits, solvable exactly or approximately by classical methods |
| Quantum sensing in medicine | Optically pumped magnetometers allow wearable brain-activity sensors without cryogenic cooling |
Where quantum computing could help
Molecular simulation for drug and biologic design
The problem: Predicting how strongly a candidate drug binds to its target, and how enzymes metabolize it, requires accurate electronic structure calculations. For metal-containing enzymes such as cytochrome P450, which processes most drugs in the body, strong electron correlation limits the accuracy of standard classical approximations.
The quantum approach: Quantum phase estimation and related algorithms can compute ground-state energies with guaranteed accuracy on a fault-tolerant machine. Near-term hybrid methods such as the variational quantum eigensolver use short circuits and a classical optimizer.
Where things stand: Published resource estimates for cytochrome P450 and similar systems point to millions of physical qubits and hours to days of runtime. Near-term demonstrations are on very small molecules that classical computers solve exactly. Meanwhile AI structure predictors have transformed the field in ways that reduce the immediate need for quantum methods.
Related algorithms: Quantum Phase Estimation (QPE), Variational Quantum Eigensolver (VQE), Trotter-Suzuki Decomposition
Genomics and sequence analysis
The problem: Assembling genomes from short reads, aligning sequences, and finding variants involve searching and optimizing over enormous sets of strings, and the data volumes keep growing.
The quantum approach: Researchers have formulated assembly and alignment as optimization problems for quantum annealers and QAOA, and have studied Grover-style search for pattern matching.
Where things stand: Quadratic speedups from search algorithms do not overcome the data-loading cost for genomes, and classical tools built on indexing structures such as the Burrows-Wheeler transform are extremely efficient. Demonstrations are on toy-sized problems, so genomics is a research direction, not a near-term application.
Related algorithms: Grover's Algorithm, Quantum Annealing, Quantum Approximate Optimization Algorithm (QAOA)
Medical imaging and diagnostic machine learning
The problem: Classifying scans, segmenting tumors, and predicting outcomes from imaging and electronic health records are machine learning tasks where labeled data is scarce and accuracy matters.
The quantum approach: Quantum kernels and variational classifiers are being tested on small imaging datasets, with the aim of finding features that classical models miss.
Where things stand: Published studies use tiny datasets, often downsampled, and report accuracy comparable to classical baselines. Theoretical work, including results on the power of data in quantum machine learning, suggests that classical models with enough data are hard to beat on typical tasks, so a clear advantage in imaging has not been demonstrated.
Related algorithms: Quantum Kernel Estimation, Quantum Support Vector Machine, Quantum Anomaly Detection
Treatment planning and hospital operations
The problem: Radiation therapy plans must deliver dose to a tumor while sparing healthy tissue, subject to many constraints, and hospitals must schedule staff, operating rooms, and equipment under tight rules.
The quantum approach: These problems are cast as constrained optimization and attacked with QAOA, annealing, and hybrid solvers.
Where things stand: Studies show that formulations can be mapped to quantum hardware, but at realistic sizes, classical solvers such as mixed-integer programming are faster and more accurate. The Cleveland Clinic and IBM installed an on-site quantum computer in 2023 as part of a research partnership, which illustrates the interest, not a clinical benefit.
Related algorithms: Quantum Approximate Optimization Algorithm (QAOA), Quantum Annealing, Quantum Approaches to the Traveling Salesman Problem
Who is working on it
- Cleveland Clinic and IBM, which placed an IBM Quantum System One on a hospital campus in 2023 as part of a Discovery Accelerator partnership, the first such on-site installation in healthcare.
- Moderna and IBM, who have explored predicting mRNA secondary structure with hybrid quantum workflows, reporting studies on short sequences on an IBM device.
- Pharmaceutical and biotechnology firms such as Boehringer Ingelheim, Roche, Merck, and Amgen, which run chemistry-focused collaborations with hardware and software companies.
- Quantum sensing groups and companies developing optically pumped magnetometers for brain imaging and nitrogen-vacancy sensors for biological measurement.
- Software firms such as Quantinuum and Phasecraft, which develop chemistry and life-science algorithms.
Realistic timeline
| Horizon | What to expect |
|---|---|
| Now to 2028 | Pilots on small molecules and optimization problems, quantum sensing instruments for research, and hybrid workflows that mainly serve as testbeds. |
| 2028 to 2032 | Early fault-tolerant machines may allow chemistry calculations for small active spaces that exceed exact classical methods. Drug discovery impact is likely indirect, through better data for classical models. |
| 2032 and later | If fault-tolerant machines with thousands of logical qubits arrive, accurate simulation of metalloenzymes and reaction mechanisms could inform design. Clinical applications of computing remain speculative. |
How to judge quantum claims in this sector
Healthcare claims are easy to inflate because the end goal, a better drug or diagnosis, is far from the technical step being demonstrated. A useful habit is to separate the layers. At the bottom is a calculation, such as the energy of a molecule. Above it is a prediction, such as binding strength. Above that is a decision, such as which compound to synthesize. A quantum computer can only change the bottom layer, and its value depends on whether errors there are what limits the decision.
For machine learning claims on medical data, ask about dataset size, leakage between training and test sets, and whether the quantum model beat a well-tuned classical model, not a weak one. Studies on small, downsampled imaging data often show similar accuracy for quantum and classical classifiers, and the difference is within statistical noise. Independent replication matters more here than anywhere else.
What stands in the way
- Scale: chemically relevant systems need thousands of logical qubits, far beyond current machines.
- Competition: AI-based structure and property prediction is advancing fast, narrowing the gap quantum methods would fill.
- Validation: any new method must be validated against experiment, and drug development pipelines move slowly.
- Data and privacy: patient data rules complicate sending records to cloud quantum services.
What organizations in this sector should do now
- Identify the specific molecular problems where classical methods fail, so that quantum efforts target real bottlenecks.
- Partner with academic groups and vendors on small, well-defined benchmarks and publish results.
- Watch quantum sensing, which may reach clinics sooner than quantum computing.
- Build data governance that would allow secure use of external quantum services when they become useful.
Myths versus reality
- Myth: quantum computers will soon discover new drugs. Reality: any contribution is likely years away and will complement AI and classical simulation.
- Myth: quantum computing will read genomes instantly. Reality: data loading and classical indexing make genomics a poor fit.
- Myth: quantum sensing and quantum computing are the same thing. Reality: they are different technologies at different maturity levels.
The bottom line
Quantum computing may one day improve the accuracy of molecular simulation for hard drug targets, but that is a long-range prospect that complements AI-driven design. Quantum sensing is closer to practical use in research settings. Healthcare organizations should focus on partnerships that build expertise and avoid committing to quantum-dependent clinical plans.
Frequently asked questions
Is quantum computing being used in hospitals?
Not for patient care. Some hospitals partner on research, such as the Cleveland Clinic and IBM, but clinical applications are not yet available.
How could quantum computers help drug discovery?
By simulating molecules and reactions with high accuracy, especially for systems with strong electron correlation. Resource estimates suggest this needs fault-tolerant machines with thousands of logical qubits.
What is quantum sensing in medicine?
The use of quantum properties of atoms and spins to build sensitive detectors, such as optically pumped magnetometers for measuring brain activity. It is more mature than quantum computing.
Will quantum computers improve medical AI?
It is not shown. Quantum machine learning results on medical data match classical baselines on small datasets, and classical models with enough data are hard to beat.
When might healthcare see real benefits?
Quantum sensing may help research sooner. Computing benefits for chemistry are likely in the 2030s at the earliest, with clinical impact further out.
Keep exploring
- Algorithm: Variational Quantum Eigensolver (VQE)
- Algorithm: Quantum Phase Estimation (QPE)
- Algorithm: Quantum Kernel Estimation
- Algorithm: Quantum Approximate Optimization Algorithm (QAOA)
- Hardware: IBM Heron (r1, r2, and r3)
- Hardware: Quantinuum H2
- Company: IBM
- Company: Quantinuum
- Company: Phasecraft
- Research: Higher-Accuracy Molecular Energy Estimation Using Adaptive VQE Ansätze
- Research: Automated Active Space Selection Improves Practical VQE Chemistry Simulations
- Industry: Quantum Computing for Pharmaceuticals and Drug Discovery
- Industry: Quantum Computing for Biotechnology and Genomics
- Industry: Quantum Computing for Materials Science
- Industry: Quantum Computing for Agriculture and Food
This page is written for educational purposes and summarizes public announcements, published research, and published resource estimates (last reviewed September 30, 2026). Vendor and customer claims have not all been independently verified, timelines are estimates, and nothing here is investment or business advice.